Target intelligence / Profile preview

NADH:ubiquinone oxidoreductase complex assembly factor 4 pseudogene 3 (NDUFAF4P3)

Target: NDUFAF4P3
Molecular classification: Other (Pseudogene)

Overview

NDUFAF4P3 is a pseudogene named "NADH:ubiquinone oxidoreductase complex assembly factor 4 pseudogene 3". It is a non-protein-coding DNA segment related to NDUFAF4, which is a nuclear gene involved in mitochondrial complex I assembly. Unlike the parent NDUFAF4 gene, pseudogene 3 does not encode a protein and has no known biological or pharmacological function[1][3]. Pseudogenes such as NDUFAF4P3 are typically considered evolutionary remnants and are not used as therapeutic targets. There is no evidence of molecular function, disease association, or drug interaction for this gene in curated genomic databases.

Other names: NADH:Ubiquinone Oxidoreductase Complex Assembly Factor 4 Pseudogene 3gene symbol NDUFAF4P3

Mechanism of action

None. Pseudogenes are not known to mediate drug mechanisms of action.

Biological functions

None. Pseudogenes typically do not encode proteins and lack function in normal physiology. In rare cases, some pseudogenes might exert regulatory effects (e.g., via noncoding RNA), but NDUFAF4P3 is currently only annotated as a pseudogene and no regulatory function has been reported.

Disease associations

None. No disease associations, causative or biomarker roles are documented for NDUFAF4P3

Safety considerations

None. As a pseudogene, NDUFAF4P3 does not present therapeutic safety concerns.

Interacting drugs

None. There are no drugs reported or clinically investigated as interacting with NDUFAF4P3

Biomarkers

None. There is no evidence that NDUFAF4P3 serves as a biomarker for patient selection or disease monitoring.

Beyond the preview

Go deeper on NADH:ubiquinone oxidoreductase complex assembly factor 4 pseudogene 3 (NDUFAF4P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH:ubiquinone oxidoreductase complex assembly factor 4 pseudogene 3 (NDUFAF4P3).

Explore the full profile